whether EVERY patient with type 2 diabetes should take an ACE inhibitor or ARB, aspirin, and statin

You'll hear controversy over whether EVERY patient with type 2 diabetes should take an ACE inhibitor or ARB, aspirin, and statin.

This push is partly due to insurer pay-for-performance programs.

These drugs are often helpful...but watch for the exceptions.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote